贝叶斯的综合学习通过分散的临床试验纵向剂量反应关系的贝叶斯综合学习
Jingyi Zhang1, Tuo Wang2, Yongming Qu2
1Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Statistics in medicine
|December 3, 2025
概括
分散临床试验 (DCT) 对慢性疾病提供了好处,但面临着数据挑战. 一种新的贝叶斯方法有效地整合了来自集中和分散来源的数据,提高了分析效率并减少了偏差.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 分散临床试验 (DCT) 提高了获取和便利性,但引入了数据变化和偏差问题.
- 糖尿病和肥胖等慢性疾病需要长期研究,这使得DCT特别重要.
- 在使用混合数据源的DCT中分析剂量反应关系存在统计方面的挑战.
研究的目的:
- 开发一种新的贝叶斯集成学习程序,用于分析DCT中的剂量反应关系.
- 解决与分散数据收集相关的偏见和不确定性.
- 实现来自集中和分散来源的信息的数据适应性整合.
主要方法:
- 参数指数衰减模型的概括,以适应混合数据源 (集中和分散).
- 应用贝叶斯尖峰和板块先验来减轻分散测量的偏差和不确定性.
- 利用来自二期DCT的纵向数据,将集中和分散的数据收集结合起来.
主要成果:
- 提出的贝叶斯方法在各种模拟场景中表现良好.
- 该方法实现了与传统试验相比的效率,当分散的数据没有额外的错误时.
- 即使数据具有变化性,这种方法也显示出比天真的聚合方法更低的偏差和更高的效率.
结论:
- 新的贝叶斯集成学习程序有效地分析了混合数据的DCT中的剂量反应关系.
- 这种方法为处理来自集中和分散来源的数据提供了一个强大的框架.
- 该方法为分析DCT数据提供了统计学上合理和高效的替代方案,特别是在慢性疾病研究中.
相关概念视频
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
01:03Dose-Response Relationship: Overview
4.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.7K
01:12Analysis of Population Pharmacokinetic Data
657
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
657
01:19Nonlinear Pharmacokinetics: Overview
1.0K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.0K
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
203
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
203